Marc Casper, president and chief executive officer, Thermo Fisher Scientific. (File photo)
WALTHAM, US: Thermo Fisher Scientific Inc said it has signed a definitive agreement to acquire Johnson Matthey Plc’s research chemicals manufacturer, Alfa Aesar for £256 million (approximately $405 million) in cash. The transaction is expected to be completed by the end of 2015.
Heysham, UK-based Alfa Aesar business generated sales of approximately £78 million ($125 million) in 2014. It has 480 employees and operates in key research hubs in the US, Germany, China, South Korea and India, Thermo Fisher said.
Alfa Aesar will be integrated into Thermo Fisher’s laboratory products and services segment, it said.
“The acquisition of Alfa Aesar enhances our existing portfolio of chemicals, solvents and reagents to support virtually every laboratory application – from research to drug discovery and development, to production,” said Marc Casper, president and chief executive officer, Thermo Fisher Scientific. “In addition, customers will benefit from greater access to these products through our extensive global commercial reach.”
© Worldofchemicals News